Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) : financial budget report for 2022

Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) 2022 annual financial budget report

Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)

Financial budget report for 2022

Special tips:

The financial budget is only used as a reference index for the company’s internal operation and management and performance evaluation, and does not represent the company’s management’s profit forecast for 2022. Whether it can be realized depends on many factors such as macro-economy, market demand, industry development and the efforts of the company’s management team. There is great uncertainty, so investors should pay special attention.

1、 Budget preparation description

Based on the company’s strategic development objectives and the company’s 2021 financial report audited by Lixin Certified Public Accountants (special general partnership), this budget report comprehensively analyzes the expected impact of the company’s market and business development plan, policy changes, industry situation, market demand and other factors, and calculates and prepares it in combination with the company’s marketing plan and production and operation plan in 2022.

2、 Basic assumptions

1. There is no significant change in the current relevant national and local laws, regulations and systems followed by the company. 2. There is no significant change in the market and socio-economic environment of the company’s main business location and business areas.

3. There are no significant changes in the tax policies and relevant preferential tax policies followed by the company.

4. The company’s production and operation plans and marketing plans can be implemented smoothly without significant impact from government policies.

5. The market price and supply-demand relationship of the company’s main products and raw materials will not change significantly.

6. No other person has caused significant adverse effects due to unforeseen and force majeure factors.

3、 Basis and scope of budgeting

Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) 2022 annual financial budget report

1. The accounting policies selected in this budget report are consistent with the relevant accounting policies actually adopted by the company in all important aspects.

2. This budget is prepared on the basis of the production and operation plan and marketing plan formulated by the company.

3. This budget covers the company and all its subsidiaries.

4、 Budgeting basis

1. The operating revenue is budgeted according to the company’s strategic development objectives, taking into account the existing production capacity, target customers and the growth plan for seeking new business.

2. The cost and expense are mainly budgeted according to the gross profit margin of the company’s classified products in 2021, the actual expenditure of various expenses in 2021 and the increase or decrease of business volume in 2022.

3. The income tax is calculated based on the total profit of each company within the consolidation scope in 2022 and the applicable income tax rate.

5、 Main indicators of 2022 budget

1. Operating income increased by 20-25% over the same period last year;

2. Net profit increased by 5-10% over the same period last year;

Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) board of directors

April 22, 2022

- Advertisment -